These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
465 related items for PubMed ID: 30100039
1. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features reclassification and its impact on thyroid malignancy rate and treatment. Mao ML, Joyal T, Picado O, Kerr D, Lew JI, Farrá JC. J Surg Res; 2018 Oct; 230():47-52. PubMed ID: 30100039 [Abstract] [Full Text] [Related]
2. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort. Chung R, Guan H, Ponchiardi C, Cerda S, Marwaha N, Yilmaz OH, Pinjic E, McAneny D, Lee SL, Drake FT. Thyroid; 2021 Jan; 31(1):68-75. PubMed ID: 32539676 [Abstract] [Full Text] [Related]
3. Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology? Kopczyński J, Suligowska A, Niemyska K, Pałyga I, Walczyk A, Gąsior-Perczak D, Kowalik A, Hińcza K, Mężyk R, Góźdź S, Kowalska A. Endocr Pathol; 2020 Jun; 31(2):143-149. PubMed ID: 32236858 [Abstract] [Full Text] [Related]
4. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features and the risk of malignancy in The Bethesda System for the Reporting of Thyroid Cytopathology. Elliott Range D, Jiang XS. Diagn Cytopathol; 2020 Jun; 48(6):531-537. PubMed ID: 32167682 [Abstract] [Full Text] [Related]
5. RISK OF MALIGNANCY IN THYROID CYTOLOGY: THE IMPACT OF THE RECLASSIFICATION OF NONINVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP). Ventura M, Melo M, Fernandes G, Carrilho F. Endocr Pract; 2019 Jul; 25(7):642-647. PubMed ID: 30865528 [Abstract] [Full Text] [Related]
6. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). Zhou H, Baloch ZW, Nayar R, Bizzarro T, Fadda G, Adhikari-Guragain D, Hatem J, Larocca LM, Samolczyk J, Slade J, Rossi ED. Cancer Cytopathol; 2018 Jan; 126(1):20-26. PubMed ID: 28941185 [Abstract] [Full Text] [Related]
7. Long-term progression of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A single-center retrospective study of the French Marne-Ardennes thyroid cancer registry. Richard C, Debreuve-Theresette A, Patey M, Brabencova E, Filieri C, Zalzali M, Schvartz C. Ann Endocrinol (Paris); 2020 Feb; 81(1):34-38. PubMed ID: 32057425 [Abstract] [Full Text] [Related]
13. Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas. Boursier L, Clerc Urmes I, Garon J, Klein M, Demarquet L. Ann Endocrinol (Paris); 2020 Feb; 81(1):28-33. PubMed ID: 32081363 [Abstract] [Full Text] [Related]
18. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery. Lindeman BM, Nehs MA, Angell TE, Alexander EK, Gawande AA, Moore FD, Doherty GM, Cho NL. Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576 [Abstract] [Full Text] [Related]
19. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is rare, benign lesion using modified stringent diagnostic criteria: Reclassification and outcome study. Cubero Rego D, Lee H, Boguniewicz A, Jennings TA. Ann Diagn Pathol; 2020 Feb; 44():151439. PubMed ID: 31865250 [Abstract] [Full Text] [Related]